Published in Endocrinology on July 01, 1995
Molecular clustering of endometrial carcinoma based on estrogen-induced gene expression. Cancer Biol Ther (2009) 1.02
Changes in global gene expression in rat myometrium in transition from late pregnancy to parturition. Physiol Genomics (2008) 0.81
Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res (2000) 1.55
A case of a laboratory animal feed with high estrogenic activity and its impact on in vivo responses to exogenously administered estrogens. Environ Health Perspect (1998) 1.55
Estrogen receptor-mediated processes in normal and cancer cells. J Natl Cancer Inst Monogr (2000) 1.50
Progestin regulation of vascular endothelial growth factor in human breast cancer cells. Cancer Res (1998) 1.44
Regulation of epidermal growth factor receptor by estrogen. J Biol Chem (1985) 1.32
Estrogen regulation of c-fos messenger ribonucleic acid. Mol Endocrinol (1988) 1.22
Estrogen regulation of epidermal growth factor receptor messenger ribonucleic acid. Mol Endocrinol (1988) 1.12
Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen. Cancer Res (1996) 1.10
Regulation of vascular endothelial growth factor expression by estrogens and progestins. Environ Health Perspect (2000) 1.07
Regulation of angiogenic growth factors in the female reproductive tract by estrogens and progestins. Mol Endocrinol (1999) 1.06
Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells. Int J Cancer (2001) 1.05
Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780. Cancer Res (1997) 0.97
Reversible dissociation of yeast glyceraldehyde 3-phosphate dehydrogenase by adenosine triphosphate. Biochemistry (1969) 0.96
DDT supports the growth of an estrogen-responsive tumor. Toxicol Lett (1985) 0.96
The protooncogene c-jun contains an unusual estrogen-inducible enhancer within the coding sequence. J Biol Chem (1995) 0.94
Regulation of uterine epidermal growth factor (EGF) receptors by estrogen in the mature rat and during the estrous cycle. J Steroid Biochem (1989) 0.93
Interaction of human estrogen receptors alpha and beta with the same naturally occurring estrogen response elements. Biochem Pharmacol (1999) 0.93
Hormonal control of transcription in the rat uterus. Stimulation of deoxyribonucleic acid-dependent RNA polymerase III by estradiol. J Biol Chem (1977) 0.91
Progesterone inhibits the estrogen-induced expression of c-fos messenger ribonucleic acid in the uterus. Endocrinology (1992) 0.91
Receptors for epidermal growth factor in the rat uterus. Endocrinology (1985) 0.90
Steroid hormone-induced expression of oncogene encoded nuclear proteins. Crit Rev Eukaryot Gene Expr (1994) 0.88
Estrogen receptors in the rat uterus. Multiple forms produced by concentration-dependent aggregation. Biochemistry (1973) 0.88
Estrogenic activity of DDT: estrogen-receptor profiles and the responses of individual uterine cell types following o,p'-DDT administration. J Toxicol Environ Health (1985) 0.88
Regulation of VEGF in the reproductive tract by sex-steroid hormones. Histol Histopathol (2000) 0.88
Identification of an estrogen response element in the 3'-flanking region of the murine c-fos protooncogene. J Biol Chem (1992) 0.87
Contractions of the isolated uterus stimulated by epidermal growth factor. FASEB J (1987) 0.87
Most of the G1 period in hamster cells is eliminated by lengthening the S period. Proc Natl Acad Sci U S A (1981) 0.87
Synthetic estrogen 17alpha-ethinyl estradiol induces pattern of uterine gene expression similar to endogenous estrogen 17beta-estradiol. J Pharmacol Exp Ther (1999) 0.85
The pure antiestrogen ICI 182,780 inhibits progestin-induced transcription. Cancer Res (1999) 0.85
Activation of mammalian cyclic AMP phosphodiesterases by trypsin. Biochim Biophys Acta (1978) 0.84
Evidence for thyroid hormone receptors in uterine nuclei. Metabolism (1983) 0.83
Estrogen regulates expression of the jun family of protooncogenes in the uterus. J Steroid Biochem Mol Biol (1992) 0.83
The influence of sex hormones on antidepressant-induced alterations in neurotransmitter receptor binding. J Neurosci (1982) 0.82
The effect of hypophysectomy on the uterine response to estradiol. Endocrinology (1977) 0.82
Presence of an estradiol response region in the mouse c-fos oncogene. Steroids (1991) 0.81
Stimulatory and inhibitory effects of estrogen and antiestrogen on uterine cell division. Endocrinology (1981) 0.81
Regulation of the uterine response to estrogen by thyroid hormone. Endocrinology (1978) 0.81
Analysis of cytoplasmic and nuclear estrogen-receptor proteins by sucrose density gradient centrifugation. Methods Enzymol (1975) 0.80
Triphenylethylene antiestrogens induce uterine vascular endothelial growth factor expression via their partial estrogen agonist activity. Cancer Lett (1997) 0.80
Elevation of protooncogene messenger RNAs in estrogen-induced kidney tumors in the hamster. Carcinogenesis (1992) 0.80
Induction of the angiogenic factor VEGF in the uterus by the antiprogestin onapristone. Cancer Lett (2000) 0.80
Estrogen receptors in the rat uterus. Relationship between cytoplasmic and nuclear forms of the estrogen binding protein. Biochemistry (1973) 0.80
Imipramine: effect of ovarian steroids on modifications in serotonin receptor binding. Science (1981) 0.80
Cultured human uterine smooth muscle cells are retinoid responsive. Proc Soc Exp Biol Med (1997) 0.79
Oncogenes and uterine function. Oxf Rev Reprod Biol (1993) 0.79
Tamoxifen stimulates expression of the c-fos proto-oncogene in rodent uterus. Mol Pharmacol (1993) 0.79
Hormonal carcinogenesis: separation of estrogenicity from carcinogenicity. Chem Biol Interact (1986) 0.79
Evidence for convertible forms of soluble uterine cyclic nucleotide phosphodiesterase. Biochim Biophys Acta (1981) 0.79
Separation of multiple forms of cyclic nucleotide phosphodiesterases from rat brain by isoelectrofocusing. Biochim Biophys Acta (1974) 0.79
Hormonal control of uterine growth: alterations in luminal epithelial deoxyribonucleic acid synthesis after intraluminal application of estrogen. Endocrinology (1984) 0.78
Decreased cell division of the uterine luminal epithelium of diabetic rats in response to 17 beta-estradiol. Endocrinology (1981) 0.78
In vitro interaction of uterine estrogen receptor with the estrogen response element present in the 3'-flanking region of the murine c-fos protooncogene. J Steroid Biochem Mol Biol (1994) 0.78
Stimulation of uterine deoxyribonucleic acid synthesis by 1,1,1-trichloro-2-(p-chlorophenyl)-2-(o-chlorophenyl)ethane (o,p'-DDT). Biochem Pharmacol (1980) 0.78
Effect of a diabetic state on myometrial ultrastructure and isolated uterine contractions in the rat. Proc Soc Exp Biol Med (1985) 0.78
The estrogenic activity of DDT: in vivo and in vitro induction of a specific estrogen inducible uterine protein by o,p'-DDT. Life Sci (1980) 0.78
The estrogenic activity of DDT: correlation of estrogenic effect with nuclear level of estrogen receptor. Life Sci (1982) 0.78
Effects of estrogen on mitosis in individual cell types of the immature rat uterus. Biol Reprod (1979) 0.78
Characterization of soluble uterine cyclic nucleotide phosphodiesterase. Biochemistry (1978) 0.77
An approach to the development of quantitative models to assess the effects of exposure to environmentally relevant levels of endocrine disruptors on homeostasis in adults. Environ Health Perspect (1999) 0.77
Autoradiographic localization of epidermal growth factor receptors to all major uterine cell types. Biol Reprod (1988) 0.77
Estrogen action in target cells: selective requirements for activation of different hormone response elements. Mol Cell Endocrinol (1995) 0.77
The estrogenic activity of DDT: the in vitro induction of an estrogen-inducible protein by o,p'-DDT. Toxicol Appl Pharmacol (1984) 0.77
Cellular pattern of c-fos induction by estradiol in the immature rat uterus. Biol Reprod (1995) 0.76
Selective blockade of estrogen-induced uterine responses by the antiestrogen nafoxidine. Endocrinology (1978) 0.76
Neonatal exposure to diethylstilbestrol permanently alters the basal and 17 beta-estradiol induced expression of c-fos proto-oncogene in mouse urethroprostatic complex. Mol Cell Endocrinol (1997) 0.75
Hormonal control of uterine growth: the effect of hypothyroidism on estrogen-stimulated cell division. Endocrinology (1981) 0.75
Creation of an active estrogen-responsive element by a single base change in the flanking sequence of a cellular oncogene: a possible mechanism for hormonal carcinogenesis? Mol Carcinog (1993) 0.75
Effect of ovariectomy and estrogen treatment on uterine benzylamine oxidase and monoamine oxidase type A. Res Commun Chem Pathol Pharmacol (1983) 0.75
Cyclic nucleotide phosphodiesterases in uterine development. Mol Cell Endocrinol (1975) 0.75
Binding and function of serotonin 2 receptors following chronic administration of imipramine. Neuropharmacology (1984) 0.75
Regulation of deoxyribonucleic acid polymerase activity in uterine luminal epithelium after multiple doses of estrogen. Endocrinology (1988) 0.75
Metabolic control and structure of glycolytic enzymes. V. Dissociation of yeast glyceraldehyde-3-phosphate dehydrogenase into subunits by ATP. Biochem Biophys Res Commun (1968) 0.75
Hormonal control of uterine growth: temporal relationships between estrogen administration and deoxyribonucleic acid synthesis. Endocrinology (1982) 0.75
The 3-flanking region of the mouse c-fos gene contains a cluster of GGTCA hormone response-like elements. Mol Biol Rep (1998) 0.75
Estrogen receptors in the rat uterus. Retention of hormone-receptor complexes. Biochemistry (1976) 0.75
Phorbol ester inhibition of estrogen-induced uterine deoxyribonucleic acid synthesis. Biol Reprod (1998) 0.75
Effects of experimentally-induced diabetes on oestradiol-stimulated changes in the ultrastructure of the rat endometrium. Acta Endocrinol (Copenh) (1985) 0.75
The influence of hormones on drug-induced modifications in neurotransmitter receptor binding. Prog Clin Biol Res (1982) 0.75
Blockade of epidermal growth factor-induced uterine contractions by indomethacin or nordihydroguaritic acid. J Pharmacol Exp Ther (1989) 0.75
Progesterone inhibits estrogen-induced increases in c-fos mRNA levels in the uterus. Recent Prog Horm Res (1993) 0.75